Table 2.
Cardiovascular and renal profile of the study population according to UACR and eGFR
| Controls (n = 40) | A-DKD (n = 41) | NA-DKD (n = 41) | AL-DKD (n = 38) | |
|---|---|---|---|---|
| PWV, m/s | 10.24 ± 2.67 | 10.64 ± 3.62 | 11.83 ± 3.74* | 11.99 ± 3.98* |
| AugI, % | 29.30 ± 9.99 | 32.00 ± 12.01 | 28.36 ± 6.26 | 31.83 ± 9.48 |
| Carotid plaque, no. (%) | 12 (31) | 17 (41) | 24 (59)* | 28 (74)*† |
| qIMT, mm | 0.81 ± 0.14 | 0.81 ± 0.15 | 0.83 ± 0.12 | 0.86 ± 0.11 |
| RRI | 0.71 ± 0.09 | 0.71 ± 0.08 | 0.76 ± 0.11*† | 0.77 ± 0.08*† |
| RV/BSA (mL/m2) | 80.15 ± 24.08 | 91.45 ± 29.94 | 78.57 ± 17.04† | 84.12 ± 26.67 |
Data are presented as mean ± SD or percentage. A-DKD: albuminuric diabetic kidney disease (UACR ≥ 30 mg/g and eGFR ≥ 60 mL/min/1.63 m2); NA-DKD: non-albuminuric diabetic kidney disease (UACR < 30 mg/g and eGFR < 60 mL/min/1.63 m2); AL-DKD: albuminuric and low estimated glomerular filtration rate diabetic kidney disease (UACR ≥ 30 mg/g and eGFR < 60 mL/min/1.63 m2); UACR: urinary albumin to creatine ratio; eGFR: estimated glomerular filtration rate; PWV: pulse wave velocity; AugI: augmentation index; qIMT: quality intima-media thickness; RRI: renal resistivity index; RV/BSA: renal volume/body surface index. *P < 0.05 versus group A; †P < 0.05 versus group B; ‡P < 0.05 versus group C